Targeting Growth in Health Care
Biotech companies addressing unmet medical needs with novel treatments can be a great source of growth in a slow-growth environment, says Evan Bauman of Legg Mason ClearBridge.
Shannon Zimmerman: For Morningstar, I'm Shannon Zimmerman. I'm here today with Evan Bauman of Legg Mason ClearBridge Aggressive Growth.
Evan, thank you very much for being with us today.
Shannon Zimmerman does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.